NA
CRHM

Navellier & Associates’s CRH Medical Corporation CRHM Stock Holding History

Navellier & Associates’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,100
Closed -$137K – 323
2017
Q2 		$137K Hold
24,100
– – 0.02% 285
2017
Q1 		$198K Buy
+24,100
New +$167K 0.03% 273

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Navellier & Associates's CRHM Position: Q3 2017 in Review

Navellier & Associates sold out of CRH Medical Corporation (CRHM) in Q3 2017, closing a stake of 24,100 shares — an estimated $137K sold.

Navellier & Associates first reported a position in CRHM in Q1 2017 and held it in 2 quarters. The position peaked at $198K in Q1 2017. 44 funds tracked by Wall St. Rank hold CRHM as of Q3 2017.

  • Navellier & Associates reported no remaining CRH Medical Corporation position as of Q3 2017 after selling out during the quarter.
  • Navellier & Associates sold 24,100 CRH Medical Corporation shares in Q3 2017, an estimated $137K.
  • Navellier & Associates first reported a position in CRH Medical Corporation in Q1 2017 and held it in 2 quarters.
  • Navellier & Associates's CRH Medical Corporation position peaked at $198K in Q1 2017.
  • 44 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q3 2017.

Based on Navellier & Associates's 13F filing for Q3 2017, filed 14 Nov 2017.